Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Updated the page's revision history to include Revision: v3.5.4 and remove Revision: v3.5.3, reflecting the latest document version.
    Difference
    0.0%
    Check dated 2026-05-18T05:57:19.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Taoyuan District listing was replaced with Taoyuan, reflecting a city-level designation with the same postal code 33305. This aligns the location with the actual site and improves accuracy for recruitment and contact information.
    Difference
    0.0%
    Check dated 2026-05-04T01:32:07.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s displayed software/site revision indicator has been updated from v3.5.0 to v3.5.3. This represents a maintenance/frontend version change rather than an update to the clinical trial information presented.
    Difference
    0.0%
    Check dated 2026-04-26T15:20:58.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Site listing updated from Napoli, Italy, 80131 to Naples, Italy, 80131. Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T16:32:52.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:40:12.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; this is a minor maintenance update with no visible changes to study data or navigation, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:35:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.